News Archive

2019

October

Media Release / Oct 01, 2019

Novartis Entresto receives FDA approval for pediatric heart failure, helping to address critical unmet need for treatment options

Read More

September

Media Release / Sep 19, 2019

AveXis presents new data at EPNS continuing to show significant therapeutic benefit of Zolgensma® in prolonging event-free survival now up to 5 years of age in patients with spinal muscular atrophy (SMA) Type 1

Read More
Media Release / Sep 16, 2019

Initiation of Novartis Entresto in-hospital included in the new ACC Expert Consensus Decision Pathway developed to improve management of hospitalized heart failure patients

Read More
Media Release / Sep 02, 2019

Entresto improved measures of heart structure and function in HFrEF patients in new Novartis study; additional data complement findings

Read More

July

Media Release / Jul 22, 2019

Novartis Teams Up With Celebrity Interior Designer Nate Berkus To Launch My Home In Sight, A Program Empowering People With Wet AMD To Live More Independently At Home

Read More
Media Release / Jul 16, 2019

FDA accepts file and accelerates review of Novartis sickle cell disease medicine crizanlizumab (SEG101)

Read More
Media Release / Jul 11, 2019

Novartis Offers Free Genetic Mutation Testing Program for Advanced Melanoma Patients; Results Can Help Doctors and Patients Making Cancer Treatment Decisions

Read More

June

Media Release / Jun 04, 2019

Long-term Survival Benefit Shown for Metastatic Melanoma Patients Treated with Novartis Tafinlar® + Mekinist®

Read More
Media Release / Jun 03, 2019

Novartis Shows Growing Strength in Lung Cancer Innovation with New Capmatinib Investigational Data and Novel Canakinumab Clinical Trials

Read More

May

Media Release / May 24, 2019

AveXis Announces Innovative Zolgensma® Gene Therapy Access Programs for US Payers and Families

Read More

Related Links